(BSCP) Invesco BulletShares 2025 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138J8255

BSCP: Corporate Bonds, Investment-Grade, 2025 Maturity

The Invesco BulletShares 2025 Corporate Bond ETF (BSCP) is designed to track the performance of a portfolio of investment-grade corporate bonds maturing in 2025, providing investors with a targeted maturity date and exposure to the U.S. dollar-denominated corporate bond market.

The funds investment strategy is to allocate at least 80% of its assets to securities that comprise the underlying index, which is composed of high-quality corporate bonds with maturities in 2025. This approach allows investors to benefit from a diversified portfolio of bonds with a specific maturity date, reducing the risk associated with bond ladder management.

From a technical analysis perspective, the ETFs price action indicates a stable trend, with the short-term and long-term moving averages converging, suggesting a potential breakout or consolidation phase. The Average True Range (ATR) of 0.02 (0.08%) indicates low volatility, making it an attractive option for investors seeking predictable returns.

Considering the funds Assets Under Management (AUM) of $3.37 billion, it is evident that BSCP has a significant presence in the market, providing liquidity and stability. As the maturity date approaches, the funds holdings will gradually mature, reducing credit risk and potentially leading to a more predictable return profile.

Based on the technical and fundamental data, a forecast for BSCP suggests that the ETF may continue to trade within a narrow range, potentially breaking out above the 52-week high of $20.71 if market conditions remain favorable. As the fund approaches its target maturity date, investors can expect a gradual reduction in credit risk and an increase in the proportion of cash or near-cash holdings, potentially leading to a more stable return profile. As such, BSCP may be an attractive option for investors seeking a low-risk, income-generating investment with a specific maturity date.

Additional Sources for BSCP ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BSCP ETF Overview

Market Cap in USD 3,343m
Category Target Maturity
TER 0.10%
IPO / Inception 2015-10-07

BSCP ETF Ratings

Growth Rating 35.7
Fundamental -
Dividend Rating 71.3
Rel. Strength -7.93
Analysts -
Fair Price Momentum 20.27 USD
Fair Price DCF -

BSCP Dividends

Dividend Yield 12m 4.15%
Yield on Cost 5y 4.43%
Annual Growth 5y 8.34%
Payout Consistency 94.8%
Payout Ratio %

BSCP Growth Ratios

Growth Correlation 3m 99.3%
Growth Correlation 12m 99.9%
Growth Correlation 5y 25.4%
CAGR 5y 1.52%
CAGR/Max DD 5y 0.16
Sharpe Ratio 12m 0.91
Alpha 1.16
Beta 0.001
Volatility 5.72%
Current Volume 438.5k
Average Volume 20d 534.9k
What is the price of BSCP shares?
As of June 29, 2025, the stock is trading at USD 20.69 with a total of 438,456 shares traded.
Over the past week, the price has changed by +0.16%, over one month by +0.45%, over three months by +1.16% and over the past year by +5.37%.
Is Invesco BulletShares 2025 a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Invesco BulletShares 2025 (NASDAQ:BSCP) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.69 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BSCP is around 20.27 USD . This means that BSCP is currently overvalued and has a potential downside of -2.03%.
Is BSCP a buy, sell or hold?
Invesco BulletShares 2025 has no consensus analysts rating.
What are the forecasts for BSCP share price target?
According to our own proprietary Forecast Model, BSCP Invesco BulletShares 2025 will be worth about 21.9 in June 2026. The stock is currently trading at 20.69. This means that the stock has a potential upside of +5.85%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.9 5.8%